1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study
2017) In Alzheimer's and Dementia: Translational Research and Clinical Interventions 3(3). p.393-401(
- Contribution to journal › Article
- 2010
-
Mark
Stroke: Working Toward a Prioritized World Agenda
(
- Contribution to journal › Article
-
Mark
Stroke: Working toward a Prioritized World Agenda
(
- Contribution to journal › Article
-
Mark
Stroke: working toward a prioritized world agenda
(
- Contribution to journal › Debate/Note/Editorial